Literature DB >> 11815408

Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D.

Peter R Holt1, Nadir Arber, Balazs Halmos, Kenneth Forde, Harry Kissileff, Katherine A McGlynn, Steven F Moss, N Kurihara, K Fan, Kunhua Yang, Martin Lipkin.   

Abstract

Epidemiological evidence suggests a potential role for vitamin D in colon cancer prevention. Vitamin D, absorbed from the intestine or derived from solar ultraviolet light, is metabolized in the liver to 25-hydroxyvitamin D (25-OH D(3)). Previous studies examining effects of vitamin D upon carcinogenesis have focused upon the active metabolite 1,25-dihydroxyvitamin D [1,25-(OH)(2) D(3)], which interacts with nuclear vitamin D receptors in several organs. Until recently, the metabolism of 25-OH D(3) to 1,25-(OH)(2) D(3) was believed to occur only in the kidney, but more recent studies have shown that 25-OH D(3) conversion to 1,25-(OH)(2) D(3) can occur in other tissues. We examined the association between fasting levels of 25-OH D(3), 1,25-(OH)(2) D(3), and BsmI polymorphism of the vitamin D receptor (VDR) gene with indices of colonic epithelial cell proliferation and differentiation in a chemoprevention study, after giving vitamin D or calcium and taking rectal biopsies that were incubated with bromodeoxyuridine. Vitamin D receptor polymorphism was determined by genotyping of the 3' BsmI polymorphism in intron eight of the VDR gene. No significant changes in cell proliferation or in differentiation were found in subjects between study start and end. However, fasting serum levels of 25-OH D(3) showed a highly significant decrease with whole crypt labeling index and the size of the proliferative compartment (phi h). There was no correlation between serum levels of 1,25-(OH)(2) D(3) and the proliferative parameters. Calcium supplementation induced a significant effect upon the relationship between serum 25-OH D(3) and rectal epithelial cell labeling index and phi h when studied by covariance analysis without a relationship with 1,25-(OH)(2) D(3) levels. VDR genotype did not influence the effects of serum 25-OH D(3) or serum 1,25-(OH)(2) D(3) levels upon proliferation. These data suggest that there might be a local effect of 25-OH D(3) on colonic epithelial cells through conversion of 25-OH D(3) to 1,25-(OH)(2) D(3). Subsequent studies have demonstrated the presence of 1alpha-hydroxylase mRNA in normal colorectal epithelium and in colorectal cancer. Thus, vitamin D may have an important role in determining the effects of calcium on colorectal epithelial proliferation and may explain some of the discrepancies found previously in studies that examine the direct role of calcium on the colorectal epithelium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815408

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  44 in total

Review 1.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

Authors:  Clifford J Rosen; John S Adams; Daniel D Bikle; Dennis M Black; Marie B Demay; JoAnn E Manson; M Hassan Murad; Christopher S Kovacs
Journal:  Endocr Rev       Date:  2012-05-17       Impact factor: 19.871

2.  Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Emerging role of vitamin D in colorectal cancer.

Authors:  Wonmo Kang; Sujin Lee; Eunyi Jeon; Ye-Rang Yun; Kook-Hyun Kim; Jun-Hyeog Jang
Journal:  World J Gastrointest Oncol       Date:  2011-08-15

4.  Increasing longevity by tuning up metabolism. To maximize human health and lifespan, scientists must abandon outdated models of micronutrients.

Authors:  Bruce N Ames
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

5.  Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis.

Authors:  Kathleen M Wesa; Neil H Segal; Angel M Cronin; Daniel D Sjoberg; Gria N Jacobs; Marci I Coleton; Martin Fleisher; Ann M Dnistrian; Leonard B Saltz; Barrie R Cassileth
Journal:  Nutr Cancer       Date:  2015-02-03       Impact factor: 2.900

Review 6.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

7.  Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study.

Authors:  Hidetoshi Mezawa; Tsutomu Sugiura; Michiaki Watanabe; Chihiro Norizoe; Daisuke Takahashi; Akira Shimojima; Seryna Tamez; Yusuke Tsutsumi; Katsuhiko Yanaga; Mitsuyoshi Urashima
Journal:  BMC Cancer       Date:  2010-07-02       Impact factor: 4.430

Review 8.  Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Authors:  Ruoxu Dou; Kimmie Ng; Edward L Giovannucci; JoAnn E Manson; Zhi Rong Qian; Shuji Ogino
Journal:  Br J Nutr       Date:  2016-05       Impact factor: 3.718

9.  Ex vivo culture of primary human colonic tissue for studying transcriptional responses to 1α,25(OH)2 and 25(OH) vitamin D.

Authors:  Brandon Mapes; Meredith Chase; Ellie Hong; Anton Ludvik; Katy Ceryes; Yong Huang; Sonia S Kupfer
Journal:  Physiol Genomics       Date:  2014-02-18       Impact factor: 3.107

10.  Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry.

Authors:  Jenny N Poynter; Elizabeth T Jacobs; Jane C Figueiredo; Won H Lee; David V Conti; Peter T Campbell; A Joan Levine; Paul Limburg; Loic Le Marchand; Michelle Cotterchio; Polly A Newcomb; John D Potter; Mark A Jenkins; John L Hopper; David J Duggan; John A Baron; Robert W Haile
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.